Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Shah
    Shah
  3. Perales
    Perales
  4. Scordo
    Scordo
  5. O'Reilly
    O'Reilly
  6. Tamari
    Tamari
  7. Devlin
    Devlin
  8. Castro-Malaspina
    Castro-Malaspina
  9. Gyurkocza
    Gyurkocza
  10. Jakubowski
    Jakubowski

Groups

  1. Bone Marrow Transplant (27)
  2. CTCR Scholars (27)
  3. Center for Hematologic Malignancies (27)
  4. Department of Medicine (27)
  5. Hematologic Malignancies, Division of (27)
  6. Pediatrics, Department of (27)
  7. Survivorship Research (27)
  8. Stem Cell Transplantation and Cellular Therapy Service (24)
  9. GSK Faculty (22)
  10. Immunology Program Faculty (22)
Search Within
  1. "Pediatrics, Department of"
  2. "Gunjan Shah"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (9)
Groups
  1. Bone Marrow Transplant (27)
  2. CTCR Scholars (27)
  3. Center for Hematologic Malignancies (27)
  4. Department of Medicine (27)
  5. Hematologic Malignancies, Division of (27)
  6. Pediatrics, Department of (27)

More Groups

People
  1. Gunjan Shah (27)
  2. Sergio Giralt (27)
  3. Miguel-Angel Perales (23)
  4. Michael Scordo (22)
  5. Molly Maloy (21)
  6. Richard O'Reilly (21)

More People

Years
  1. 2023 (3)
  2. 2022 (1)
  3. 2020 (3)
  4. 2019 (6)
  5. 2018 (8)
  6. 2017 (5)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (23)
  2. Clinical Lymphoma, Myeloma and Leukemia (3)
  3. Transplantation and Cellular Therapy (1)

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Ghosh, A.; Nagel, K.; Hosszu, K.; Datta, A.; Thompson, C.; Levia, K.; Kamrowski, A.; McAvoy, D.; Chung, D.; Landau, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Patel, D.; Tan, C. R.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Evaluation of melphalan exposure in lymphoma patients undergoing BEAM and autologous hematopoietic cell transplantation
    Journal Article

    Dahi, P. B.; Lin, A.; Scordo, M.; Flynn, J. R.; Devlin, S. M.; Ruiz, J. D.; DeRespiris, L.; Carlow, D.; Cho, C.; Lahoud, O. B.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Population pharmacokinetic model demonstrates poor outcomes with ATG overexposure in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; Shah, G. L.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Presalvage international staging system stage and other important outcome associations in CD34(+)-selected allogeneic hematopoietic stem cell transplantation for multiple myelomas
    Journal Article

    Bryant, A. R.; Hilden, P.; Giralt, S.; Chung, D. J.; Maloy, M.; Landau, H.; Landgren, O.; Scordo, M.; Shah, G.; Smith, E. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparison of double unit cord blood transplants (dCBT) with 8/8 HLA-allele matched related (MRD) or unrelated donor (MUD) T-cell depleted (TCD) transplants in adults with myeloid malignancies: Comparable progression-free survival (PFS)
    Meeting Abstract

    Politikos, I.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Naputo, K.; O'Reilly, R. J.; Scaradavou, A.; Castro-Malaspina, H.; Dahi, P. B.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Engrafting unit-recipient HLA-allele mismatch is not associated with an increased risk of transplant-related mortality (TRM) or inferior progression-free survival (PFS) after double unit cord blood (CB) transplantation (dCBT) in adults with hematologic malignancies
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Maloy, M. A.; Mazis, C.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation (dCBT) supplemented with haplo-identical CD34+ cells may be associated with enhanced neutrophil recovery but successful myeloid bridging is strongly influenced by haplo CD34+ cell dose and haplo-winning CB unit HLA-match
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M. A.; Naputo, K.; Afuye, A.; Avecilla, S. T.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save